Moreover, nuclear β-catenin is typically 5-20 times higher in CRC than in PDAC [40], thus possibly altering levels of a different set of target genes, which, in turn, could affect factors such as MUC4 promoter methylation and histone acetylation. This evidence concerns the gene MUC4 and colorectal carcinoma.